p53 is one of the most important molecules in HNSCC cancer tumorigenicity, because somatic mutations in the p53 gene, TP53, have been found in 60%–80% of HNSCC cases and were associated with a poor outcome of HNSCCs [35,36]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.